The Prostate Cancer Prevention Trial (PCPT) reported that 15% of men with normal serum PSA lower than 4 ng/mL and cancer-negative results after digital rectal examination had biopsy-detectable PCa [8]. This evidence concerns the gene KLK3 and prostate carcinoma.